Clyde N. Rolf

Statistics

Publications

Citations

617

H-Index

Active since

1991

Affiliations

The University of Texas Health Science Center at Houston(Current)

Texas Medical Center

Procter & Gamble (United States)

Cleveland Clinic

Clyde N. Rolf is an author at The University of Texas Health Science Center at Houston specializing in pharmacotherapy, pharmacology, and tobacco use.

Publications per year

1991–2002

Publications

Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.

David M. Daughton, Scott A. Heatley, John J. Prendergast et al. · PubMed · 1991 · 123 citations

Public Health, Pharmacotherapy, Drug Delivery +16

Real‐world efficacy of prescription and over‐the‐counter nicotine replacement therapy

Saul Shiffman, Clyde N. Rolf, Stephen J. Hellebusch et al. · Addiction · 2002 · 117 citations

Public Health, Pharmacology, Pharmacotherapy +17

β-Blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial

Jonathan M. Sorof, Paul Cargo, Jay Graepel et al. · Pediatric Nephrology · 2002 · 103 citations

Medicine, Pediatrics, Pharmacology +17

Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group

Arden G. Christen, B B Beiswanger, M.S. Mau et al. · JAMA · 1991 · 87 citations

Public Health, Pharmacology, Pharmacotherapy +17

Cholesterol Changes in Smoking Cessation Using the Transdermal Nicotine System

Sharon Allen, Dorothy K. Hatsukami, Jane Gorsline et al. · Preventive Medicine · 1994 · 47 citations

Public Health, Pharmacotherapy, Drug Delivery +12

1–5 of 9